CLOBAZAM (CLOBAZAM) — FDA Approval ANDA209687 (UPSHER SMITH LABS)
CLOBAZAM (CLOBAZAM) — FDA Approval ANDA209687 (UPSHER SMITH LABS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CLOBAZAM; Active ingredients: CLOBAZAM; Application number: ANDA209687.
| Brand name | CLOBAZAM |
|---|---|
| Active ingredients | CLOBAZAM |
| Application number | ANDA209687 |
| Sponsor | UPSHER SMITH LABS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20181022 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →